Given the chronic nature of metabolic diseases, Medical Affairs teams play a critical role in shaping product launch strategies that extend beyond clinical efficacy to focus on patient outcomes, adherence, and real-world effectiveness. Acting as the bridge between R&D, commercial teams, healthcare professionals (HCPs), and patients, Medical Affairs ensures that launch strategies meet the needs of all stakeholders, addressing both clinical and quality-of-life considerations.
Best Practices, LLC conducted this research to probe the expanding role of Medical Affairs in metabolic product launches. This report explores how Medical Affairs teams can drive successful outcomes through evolving responsibilities, enhanced cross-functional alignment, effective evidence dissemination, and strategic resourcing. Our research also highlights critical success factors, challenges, and best practices specific to the metabolic product success, providing actionable insights for Medical Affairs teams aiming to deliver high effectiveness and impact in support of launch.